INTERNATIONAL PATENT: INNOVENT CELLS PHARMACEUTICALS (SUZHOU) CO., LTD., 信达细胞制药（苏州）有限公司 FILES APPLICATION FOR "USE OF CLDN18.2 ANTIBODY AND CAR-T CELL IN TREATING CLDN18.2-POSITIVE SOLID TUMOR"

Posted On: 2025-04-19

GENEVA, April 19 -- INNOVENT CELLS PHARMACEUTICALS (SUZHOU) CO., LTD. (Building A2, 168 Dongping Street, Suzhou Industrial Park, Suzhou Area, China (Jiangsu) Pilot Free Trade ZoneSuzhou, Jiangsu 215123), 信达细胞制药（苏州）有限公司 (中国江苏省苏州市中国（江苏）自由贸易试验区苏州片区苏州工业园区东平街168号A2楼) filed a patent application (PCT/CN2024/124141) for "USE OF CLDN18.2 ANTIBODY AND CAR-T CELL IN TREATING CLDN18.2-POSITIVE SOLID TUMOR" on...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: INNOVENT CELLS PHARMACEUTICALS (SUZHOU) CO., LTD., 信达细胞制药（苏州）有限公司 FILES APPLICATION FOR "USE OF CLDN18.2 ANTIBODY AND CAR-T CELL IN TREATING CLDN18.2-POSITIVE SOLID TUMOR"